Literature DB >> 18691081

Hyaluronan as an ophthalmic viscoelastic device.

Endre A Balazs1.   

Abstract

Hyaluronan solutions known as ophthalmic viscoelastic devices (OVDs) are used in surgical procedures within the eye and on the surface of the eye to prevent dryness and to facilitate wound healing. HA and a variety of derivatives facilitate procedures including vitreoretinal surgery, anterior segment surgery, glaucoma surgery, and corneal transplantation.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18691081     DOI： 10.2174/138920108785161596

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN： 1389-2010            Impact factor:   2.837


  14 in total

1.  Improved method for synthesis of cysteine modified hyaluronic acid for in situ hydrogel formation.

Authors:  Xin Zhang; Pengcheng Sun; Lingzi Huangshan; Bi-Huang Hu; Phillip B Messersmith
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

2.  The role of hyaluronic acid precursor concentrations in molecular weight control in Streptococcus zooepidemicus.

Authors:  Wendy Yiting Chen; Esteban Marcellin; Jennifer A Steen; Lars Keld Nielsen
Journal:  Mol Biotechnol       Date:  2014-02       Impact factor: 2.695

3.  High and low molecular weight hyaluronic acid differentially influence macrophage activation.

Authors:  Jamie E Rayahin; Jason S Buhrman; Yu Zhang; Timothy J Koh; Richard A Gemeinhart
Journal:  ACS Biomater Sci Eng       Date:  2015-07-13

4.  Biophysical properties of phenyl succinic acid derivatised hyaluronic acid.

Authors:  Maria Teresa Neves-Petersen; Søren Klitgaard; Esben Skovsen; Steffen B Petersen; Kristoffer Tømmeraas; Khadija Schwach-Abdellaoui
Journal:  J Fluoresc       Date:  2009-11-28       Impact factor: 2.217

Review 5.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

6.  Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo Study.

Authors:  Yu Yu; Laurence Chi Ming Lau; Amy Cheuk-Yin Lo; Ying Chau
Journal:  Transl Vis Sci Technol       Date:  2015-03-10       Impact factor: 3.283

Review 7.  Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.

Authors:  Suniti Misra; Vincent C Hascall; Roger R Markwald; Shibnath Ghatak
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

Review 8.  Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease.

Authors:  Antonio José Mateo Orobia; Jorge Saa; Alberto Ollero Lorenzo; José María Herreras
Journal:  Clin Ophthalmol       Date:  2018-03-06

9.  Clinical efficacy of a spray containing hyaluronic Acid and dexpanthenol after surgery in the nasal cavity (septoplasty, simple ethmoid sinus surgery, and turbinate surgery).

Authors:  Ina Gouteva; Kija Shah-Hosseini; Peter Meiser
Journal:  J Allergy (Cairo)       Date:  2014-07-01

10.  Sustained Effect of Hyaluronic Acid in Subcutaneous Administration to the Cochlear Spiral Ganglion.

Authors:  Yozo Inagaki; Masato Fujioka; Sho Kanzaki; Kotaro Watanabe; Naoki Oishi; Go Itakura; Akimasa Yasuda; Shinsuke Shibata; Masaya Nakamura; Hirotaka James Okano; Hideyuki Okano; Kaoru Ogawa
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.